Find here all our blog posts tagged with: regulatory uncertainty.

Glowing molecular structures multiplying rapidly on one side and funneling through a narrow glass bottleneck on the other, symbolizing the gap between AI drug discovery and clinical trial execution.

AI Can Design a Drug. It Still Can't Get One Approved.

Generative AI is accelerating drug candidate design, but no AI-discovered molecule has reached approval because clinical trial execution and its regulatory footing remain unresolved.